Elisa Shupe Granted Copyright for AI-Generated Bookby Lilu Anderson 21.04.2024The U.S. Copyright Office grants limited copyright registration to retired U.S. Elisa Shupe, highlighting the struggle to define authorship in ...
Google Ad Impersonates Whales Market, Pushing Wallet-Drainer Malwareby John Darbie 21.04.2024Malicious ad scripts draining wallets on sites with fake domains pose a threat to users. Bing, Microsoft, and Google are ...
Uncovering the Top Fallout 76 Mods for Enhanced Gameplayby Lilu Anderson 21.04.2024Discover the top Fallout 76 mods, including Glowing Items and Text Chat Bethesda, to enhance your gaming experience. Plus, check ...
Oil Gains as Iran’s Response to Israel Strike Stays Mutedby Terry Bingman 21.04.2024Last weekend's unprecedented bombardment by Tehran has led to strikes in the Middle East, affecting global crude supply. Brent futures ...
Infosys Q4 Revenue Misses Expectations, Shares Fallby Mark Eisenberg 21.04.2024Indian company's consolidated profit jumps 30% to 79.69 billion rupees. Analysts predict stock pressure amid slow conversion for large deals.
Trump Media Stock Selloff: Thwarting Shorts with Investor Tipsby Terry Bingman 20.04.2024Short sellers are betting against the stock of the parent company of Truth Social, which has a valuation over $9 ...
Treasury Yields Climbing Towards 5%: Analyst Warns of ‘Danger Zone’by Terry Bingman 19.04.2024Vanguard warns of danger in the market due to residual long positions. Stay informed with the latest stock analysis from ...
Generation X Faces Retirement Reality Shockby Mark Eisenberg 19.04.2024Gen X is approaching retirement but many are financially unprepared. Unlike boomers, they lack traditional pensions, and the average debt ...
Exploring Retirement Visas: Turn Your Dream Into Realityby Mark Eisenberg 19.04.2024A retirement visa can make your dream of retiring abroad a reality. Research the financial and legal requirements of each ...
Breakthrough Vaccine: One Shot Protects Against All Virus Strainsby Lilu Anderson 18.04.2024Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...